EXETER, N.H.--(BUSINESS WIRE)--CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) (“CPEX” or “The Company”) today reported financial results for the second quarter ended June 30, 2009. For the quarter the Company reported revenues of $4.5 million and a net loss of $1.2 million.
